Cholinesterase Inhibitors for Lewy Body Disorders: A Meta-Analysis.

about

Improvement of Visuo-spatial Function Assessed by Raven's Colored Progressive Matrices in Dementia with Lewy Bodies by Donepezil Treatment.

P2860

Q41474641-2534E7E5-71E2-42F3-AB63-D726FD894BD7

P2860

Cholinesterase Inhibitors for Lewy Body Disorders: A Meta-Analysis.

Item

http://www.wikidata.org/entity/Q38556646

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

2015年论文

@zh

2015年论文

@zh-cn

name

Cholinesterase Inhibitors for Lewy Body Disorders: A Meta-Analysis.

@en

type

Item

label

Cholinesterase Inhibitors for Lewy Body Disorders: A Meta-Analysis.

@en

prefLabel

Cholinesterase Inhibitors for Lewy Body Disorders: A Meta-Analysis.

@en

P1476

Cholinesterase Inhibitors for Lewy Body Disorders: A Meta-Analysis

@en

P2093

Ichiro Yasue

http://www.w3.org/2001/XMLSchema#string

Shinji Matsunaga

http://www.w3.org/2001/XMLSchema#string

Taro Kishi

http://www.w3.org/2001/XMLSchema#string

P275

Creative Commons Attribution 4.0 International

P2860

Cholinesterase inhibitors for dementia with Lewy bodies, Parkinson's disease dementia and cognitive impairment in Parkinson's disease

“Mini-mental state”

Measuring inconsistency in meta-analyses

Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement

Meta-analysis in clinical trials

Efficacy of rivastigmine in dementia with Lewy bodies: a randomised, double-blind, placebo-controlled international study.

Rivastigmine for dementia associated with Parkinson's disease.

The spectrum of cognitive impairment in Lewy body diseases

The MoCA: well-suited screen for cognitive impairment in Parkinson disease.

Effects of a central cholinesterase inhibitor on reducing falls in Parkinson disease

P31

scholarly article

meta-analysis

P356

10.1093/IJNP/PYV086

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Nakao Iwata

P5008

ScienceSource

P577

2015-07-28T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

280587491

http://www.w3.org/2001/XMLSchema#string

P698

26221005

http://www.w3.org/2001/XMLSchema#string

P921

Lewy body dementia

mechanism of action

P932

4772820

http://www.w3.org/2001/XMLSchema#string

Cholinesterase Inhibitors for Lewy Body Disorders: A Meta-Analysis.

about

P2860

P2860

Cholinesterase Inhibitors for Lewy Body Disorders: A Meta-Analysis.

description

name

type

label

prefLabel

P1433

P1476

P2093

P275

P2860

P31

P356

P433

P478

P50

P5008

P577

P5875

P698

P921

P932

P356

P1433

P1476

P2093

P275

P2860

P31

P356

P433

P478

P50

P5008

P577

P5875

P698

P921

P932